Nanobiotix (NASDAQ:NBTX) Shares Gap Down – Time to Sell?

Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX)’s stock price gapped down prior to trading on Wednesday. The stock had previously closed at $32.87, but opened at $31.45. Nanobiotix shares last traded at $32.7350, with a volume of 4,674 shares traded.

Analyst Ratings Changes

A number of research analysts have recently commented on NBTX shares. Weiss Ratings restated a “sell (d-)” rating on shares of Nanobiotix in a research note on Thursday, October 15th. Guggenheim initiated coverage on Nanobiotix in a research report on Tuesday, September 15th. They set a “buy” rating and a $64.00 price target on the stock. Four analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $46.67.

Nanobiotix Price Performance

The company’s 50 day moving average is $30.53 and its 200-day moving average is $34.16.

About Nanobiotix

Nanobiotix is a French biotechnology company developing nanoparticle-based treatments for cancer. Founded in 2003, the company focuses on using nanomedicine to enhance the effects of established cancer therapies, particularly radiation therapy. Its lead product candidate, NBTXR3, is made from hafnium oxide nanoparticles and is designed to be injected directly into a tumor. When exposed to radiation, the particles are intended to increase damage to cancer cells while limiting the effect on surrounding healthy tissue.